Delivery Order SPE2DB24D2101-SPE2DB25FKLRY
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes medication. The contract is a firm fixed-price delivery order with a ceiling value of $1,245.69 and a performance period ending on June 26, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,491.38, is for the provision of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes medication. The contract is a firm fixed-price delivery order with a completion date of February 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML pharmaceutical products, with a ceiling value of $1,348.08. The contract is a firm-fixed price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 100 Unit/mL 3mL, a diabetes medication. The $12,481.58 firm fixed price contract has a completion date of May 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 200 unit/mL 3mL, a diabetes treatment medication. The contract has a ceiling value of $6,689.01 and a period of performance through May 8, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Tresiba FlexTouch 100 Unit/mL 3mL, a diabetes medication. The contract has a ceiling value of $3,552.22 and a performance period that ends on May 15, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tresiba Flextouch 200 Unit/ML 3ML, a diabetes treatment medication, with a ceiling value of $3,737.07 and a period of performance through May 30, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRESIBA FLEXTOUCH 200 UNIT/ML 3ML, a diabetes treatment medication, with a ceiling value of $2,141.37 and a period of performance extending to June 12, 2025. The contract is a firm fixed-price delivery order and is not a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRESIBA FLEXTOUCH 100 UNIT/ML 3ML, a medical product, with a ceiling value of $1,384.20 and a completion date of March 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 200 unit/mL 3mL insulin medication. The contract has a ceiling value of $1,245.69 and a completion date of July 1, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKLRYDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tresiba FlexTouch 200 unit/mL 3mL medication. The contract has a ceiling value of $6,465.72 and a performance period ending on June 24, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. This delivery order contract is part of that larger IDC, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support various government agencies, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 6/23/25 |